well said..
"... to be effective against the virus and more efficacious than Monensin. Monensin is an antibiotic which is known to have activity against
Zika in in vitro laboratory tests and was used as a control (benchmark) in this study, but due to
its in vivo toxicity cannot be used in humans."
$17B market
Baffles me to see the SP at these levels.
Add to My Watchlist
What is My Watchlist?